- Home
- BATRA vs CPRX Comparison
BATRA vs CPRX Comparison
Compare BATRA & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BATRA
- CPRX
- Stock Information
- Founded
- BATRA 1991
- CPRX 2002
- Country
- BATRA United States
- CPRX United States
- Employees
- BATRA N/A
- CPRX N/A
- Industry
- BATRA Broadcasting
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- BATRA Industrials
- CPRX Health Care
- Exchange
- BATRA Nasdaq
- CPRX Nasdaq
- Market Cap
- BATRA 2.9B
- CPRX 2.6B
- IPO Year
- BATRA N/A
- CPRX 2006
- Fundamental
- Price
- BATRA $45.58
- CPRX $20.29
- Analyst Decision
- BATRA Strong Buy
- CPRX Strong Buy
- Analyst Count
- BATRA 3
- CPRX 5
- Target Price
- BATRA $58.00
- CPRX $33.20
- AVG Volume (30 Days)
- BATRA 33.6K
- CPRX 1.4M
- Earning Date
- BATRA 11-05-2025
- CPRX 11-05-2025
- Dividend Yield
- BATRA N/A
- CPRX N/A
- EPS Growth
- BATRA N/A
- CPRX 183.96
- EPS
- BATRA N/A
- CPRX 1.65
- Revenue
- BATRA $702,443,000.00
- CPRX $558,499,000.00
- Revenue This Year
- BATRA $14.16
- CPRX $16.51
- Revenue Next Year
- BATRA $3.97
- CPRX $9.58
- P/E Ratio
- BATRA N/A
- CPRX $12.29
- Revenue Growth
- BATRA 6.51
- CPRX 28.55
- 52 Week Low
- BATRA $38.67
- CPRX $19.00
- 52 Week High
- BATRA $50.50
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- BATRA 35.92
- CPRX 47.06
- Support Level
- BATRA $46.86
- CPRX $19.17
- Resistance Level
- BATRA $48.05
- CPRX $21.19
- Average True Range (ATR)
- BATRA 0.77
- CPRX 0.72
- MACD
- BATRA -0.08
- CPRX 0.02
- Stochastic Oscillator
- BATRA 7.89
- CPRX 42.26
About BATRA Atlanta Braves Holdings Inc. Series A
Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).